A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications
Development and assessment of novel SARS-CoV-2 live attenuated vaccine (LAV) candidates using the one-to-stop (OTS) approach